(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Suture Maxon Mono Clr P12 4-0 18" 36/BX

Covidien # SMM5043 - Suture Maxon Mono Clr P12 4-0 18
Part Number Covidien SMM5043
SKU Number CIA1022085
Sell Unit BOX
Ships Within 24 Hours
List Price $491.44
Enter a valid quantity
Product Description

Covidien SMM5043 - Suture Maxon Mono Clr P12 4-0 18" 36/BX

Maxon Monofilament Absorbable Sutures

Maxon synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate.

Maxon reverse cutting needles feature tri-coined, reverse cutting edges for use in dense connective tissue and skin. The cutting edge is on the convex surface of the needle arc, facilitating needle passage while minimizing tissue cut-through. Premium reverse cutting needles are made exclusively of Surgalloy material for added strength and ductility.

Premium Reverse Cutting - Maxon 4-0 Clear 18" P-12

Item NumberStructureSuture TypeAbsorption Profile Size USPEPLength. (CM)ColorBox Qty
SMM5043MonofilamentLong-Term Absorbable180 Days4-01.545Clear36

Strength and Security for Extended Wound Healing

Maxon synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery. They are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues.

The advanced extrusion process of the molecule of polyglyconate gives the suture:

  • Excellent in-vivo strength retention
  • Excellent knot tying security
  • Minimal memory

The Strength and Flexibility You Require


Maxon Is Stronger Than The Competition During The Critical Wound Healing Period

Frequent Uses

General soft tissue approximation including fascia closure, Orthopedic surgery, Pediatric Cardiovascular surgery and patients with compromised wound healing.

Indications

Maxon and Maxon CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery. Maxon and Maxon CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues.

Contraindications

The use of this suture is contraindicated in patients with known sensitivities or allergies to its components. This suture, being absorbable, should not be used where extended approximation of tissue is required or for fixation of permanent cardiovascular prostheses or synthetic grafts.

Composition

Polyglyconate Copolymer of Glycolic Acid and Trimethylene Carbonate

Tensile Strength

80% of initial tensile strength retained at 1 week, 75% at 2 weeks, 65% at 3 weeks, 50% at 4 weeks and 25% at 6 weeks post implant

  • 2 weeks: 70%USP
  • 4 weeks: 50%USP
  • 6 weeks: 25%USP

Device Characteristics

What MRI safety information does the labeling contain?Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):No
Device labeled as "Not made with natural rubber latex":No
For Single-Use:Yes
Prescription Use (Rx):Yes
Over the Counter (OTC):No
Kit:No
Combination Product:No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):No
Related Products